https://www.tandfonline.com/doi/abs/10.1080/15412555.2019.1682535?journalCode=icop20 https://www.ncbi.nlm.nih.gov/pubmed/31682162?dopt=Abstract Phase II Study of Single/Repeated Doses of Acumapimod (BCT197) to Treat Acute Exacerbations of COPD. Phase II Study of Single/Repeated Doses of Acumapimod (BCT197) to Treat Acute Exacerbations of COPD. COPD. 2019 Nov 04;:1-10 Authors: Strâmbu IR, Kobalava ZD, Magnusson BP, MacKinnon A, Parkin JM Abstract Mitogen-activated protein kinase p38 is a key […]